About this trial
The objectives of this study are to examine how sex hormones (use of hormonal birth control, menstrual cycle phase) impact glycemic control among women with type 1 diabetes (T1D), and to test adjustments to insulin dosing and food intake to ameliorate cycle-related glycemic variability. A secondary aim is to examine how the menstrual cycle and use of hormonal birth control impact patient-reported outcomes and glycemic responses to physical activity.
Eligibility criteria
Qualifiers
Women 18-45 who have had type 1 diabetes for at least 12 months
Premenopausal with either menstrual cycles or currently using oral contraceptives
Disqualifiers
Women who are postmenopausal, pregnant, trying to become pregnant, or have had a hysterectomy
Trial design
Treatments tested in this trial
- Personalized modifications to treatment to address menstrual cycle effects on glycemia
Treatment groups
Locations
1Sponsors and collaborators
University of Colorado, Denver
Lead sponsor
The Leona M. and Harry B. Helmsley Charitable Trust
Collaborator